Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center.
Mar 5, 2021
0
2
Infectious disease specialists say they have confirmed the Mayaro virus in a patient in Haiti.
Sep 19, 2016
0
8
Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to prevent up to 12 medically important viruses, all originating from different virus families. These viruses ...
Jun 22, 2023
0
9
Cases of chikungunya continue to rise, with more than 100 people from the United States infected with the mosquito-borne virus that they contracted while out of the country, according to the Centers for Disease Control and ...
Jul 10, 2014
0
0
Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells. But by mimicking ...
Aug 2, 2023
0
1
While more than 13,000 cases of Chikungunya viral disease were reported in Brazil in 2015, scientists had never before detected the virus in a captured mosquito in this country. Now, researchers reporting in PLOS Neglected ...
Jun 22, 2017
0
0
An immune system proteinase called granzyme A appears to promote arthritic inflammation in mice infected with chikungunya virus, scientists report in a new PLOS Pathogens study. The study also suggested that granzyme A could ...
Feb 16, 2017
0
15
Chikungunya fever can cause severe and long-lasting joint pain, with several epidemics affecting multiple continents in the past decade. The illness is caused by chikungunya virus (CHIKV), but there is no effective vaccine ...
Sep 24, 2014
0
0
People infected with the chikungunya virus (CHIKV) still have an increased risk of death from complications for up to three months post-infection, according to new research published in The Lancet Infectious Diseases.
Feb 13, 2024
0
21
The National Institutes of Health-funded Vaccine and Treatment Evaluation Unit at Baylor College of Medicine will be one of the sites for a clinical trial testing the safety and immune responses to a vaccine against chikungunya ...
Jun 6, 2017
0
0
